278 related articles for article (PubMed ID: 26578655)
1. Enabling systematic interrogation of protein-protein interactions in live cells with a versatile ultra-high-throughput biosensor platform.
Mo XL; Luo Y; Ivanov AA; Su R; Havel JJ; Li Z; Khuri FR; Du Y; Fu H
J Mol Cell Biol; 2016 Jun; 8(3):271-81. PubMed ID: 26578655
[TBL] [Abstract][Full Text] [Related]
2. BRET: NanoLuc-Based Bioluminescence Resonance Energy Transfer Platform to Monitor Protein-Protein Interactions in Live Cells.
Mo XL; Fu H
Methods Mol Biol; 2016; 1439():263-71. PubMed ID: 27317001
[TBL] [Abstract][Full Text] [Related]
3. Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.
Dudgeon DD; Shinde SN; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
Assay Drug Dev Technol; 2010 Aug; 8(4):437-58. PubMed ID: 20662736
[TBL] [Abstract][Full Text] [Related]
4. Rapid screening of protein-protein interaction inhibitors using the protease exclusion assay.
Nirantar SR; Li X; Siau JW; Ghadessy FJ
Biosens Bioelectron; 2014 Jun; 56():250-7. PubMed ID: 24508816
[TBL] [Abstract][Full Text] [Related]
5. Multiplex detection of protein-protein interactions using a next generation luciferase reporter.
Verhoef LG; Mattioli M; Ricci F; Li YC; Wade M
Biochim Biophys Acta; 2016 Feb; 1863(2):284-92. PubMed ID: 26646257
[TBL] [Abstract][Full Text] [Related]
6. Using BRET to study chemical compound-induced disruptions of the p53-HDM2 interactions in live cells.
Mazars A; Fåhraeus R
Biotechnol J; 2010 Apr; 5(4):377-84. PubMed ID: 20235143
[TBL] [Abstract][Full Text] [Related]
7. Bioluminescence Resonance Energy Transfer as a Method to Study Protein-Protein Interactions: Application to G Protein Coupled Receptor Biology.
El Khamlichi C; Reverchon-Assadi F; Hervouet-Coste N; Blot L; Reiter E; Morisset-Lopez S
Molecules; 2019 Feb; 24(3):. PubMed ID: 30717191
[TBL] [Abstract][Full Text] [Related]
8. A cell-based high-throughput assay for the screening of small-molecule inhibitors of p53-MDM2 interaction.
Li J; Zhang S; Gao L; Chen Y; Xie X
J Biomol Screen; 2011 Apr; 16(4):450-6. PubMed ID: 21471462
[TBL] [Abstract][Full Text] [Related]
9. Implementation of a 220,000-compound HCS campaign to identify disruptors of the interaction between p53 and hDM2 and characterization of the confirmed hits.
Dudgeon DD; Shinde S; Hua Y; Shun TY; Lazo JS; Strock CJ; Giuliano KA; Taylor DL; Johnston PA; Johnston PA
J Biomol Screen; 2010 Aug; 15(7):766-82. PubMed ID: 20639499
[TBL] [Abstract][Full Text] [Related]
10. AKT1, LKB1, and YAP1 Revealed as MYC Interactors with NanoLuc-Based Protein-Fragment Complementation Assay.
Mo X; Qi Q; Ivanov AA; Niu Q; Luo Y; Havel J; Goetze R; Bell S; Moreno CS; Cooper LA; Johns MA; Khuri FR; Du Y; Fu H
Mol Pharmacol; 2017 Apr; 91(4):339-347. PubMed ID: 28087810
[TBL] [Abstract][Full Text] [Related]
11. Bioluminescence Resonance Energy Transfer (BRET)-Based Synthetic Sensor Platform for Drug Discovery.
Woo J; Hong J; Dinesh-Kumar SP
Curr Protoc Protein Sci; 2017 Apr; 88():19.30.1-19.30.12. PubMed ID: 28369669
[TBL] [Abstract][Full Text] [Related]
12. Use of BRET to Study Protein-Protein Interactions In Vitro and In Vivo.
Dimri S; Basu S; De A
Methods Mol Biol; 2016; 1443():57-78. PubMed ID: 27246334
[TBL] [Abstract][Full Text] [Related]
13. Reporter-Based BRET Sensors for Measuring Biological Functions In Vivo.
Rathod M; Mal A; De A
Methods Mol Biol; 2018; 1790():51-74. PubMed ID: 29858783
[TBL] [Abstract][Full Text] [Related]
14. Identification of inhibitors of Bcl-2 family protein-protein interaction by combining the BRET screening platform with virtual screening.
Park IS; Seo HR; Kim K; Lee H; Shum D; Choi I; Kim J
Biochem Biophys Res Commun; 2020 Jun; 527(3):709-715. PubMed ID: 32423828
[TBL] [Abstract][Full Text] [Related]
15. Facile analysis of protein-protein interactions in living cells by enriched visualization of the p-body.
Choi M; Baek J; Han SB; Cho S
BMB Rep; 2018 Oct; 51(10):526-531. PubMed ID: 29898808
[TBL] [Abstract][Full Text] [Related]
16. [Basic detection methods for protein-protein interaction inhibitors].
Kato M; Utata R; Tsuganezawa K; Tanaka A
Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1557-62. PubMed ID: 21089588
[No Abstract] [Full Text] [Related]
17. A yeast two-hybrid system for the screening and characterization of small-molecule inhibitors of protein-protein interactions identifies a novel putative Mdm2-binding site in p53.
Wong JH; Alfatah M; Sin MF; Sim HM; Verma CS; Lane DP; Arumugam P
BMC Biol; 2017 Nov; 15(1):108. PubMed ID: 29121928
[TBL] [Abstract][Full Text] [Related]
18. Monitoring Ligand-Activated Protein-Protein Interactions Using Bioluminescent Resonance Energy Transfer (BRET) Assay.
Coriano C; Powell E; Xu W
Methods Mol Biol; 2016; 1473():3-15. PubMed ID: 27518618
[TBL] [Abstract][Full Text] [Related]
19. Using β-Lactamase and NanoLuc Luciferase Reporter Gene Assays to Identify Inhibitors of the HIF-1 Signaling Pathway.
Khuc T; Hsu CW; Sakamuru S; Xia M
Methods Mol Biol; 2016; 1473():23-31. PubMed ID: 27518620
[TBL] [Abstract][Full Text] [Related]
20. Monitoring Hippo Signaling Pathway Activity Using a Luciferase-Based Large Tumor Suppressor (LATS) Biosensor.
Pipchuk A; Yang X
Methods Mol Biol; 2022; 2525():155-169. PubMed ID: 35836066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
